Scripps VIVO scripps research logo

  • Index
  • Log in
  • Home
  • People
  • Organizations
  • Research
  • Events
Search form

The saga of MHC-bound peptides: a renaissance for antigen presentation?

Academic Article
uri icon
  • Overview
  • Identity
  • Additional Document Info
  • View All
scroll to property group menus

Overview

authors

  • Teyton, Luc

publication date

  • November 2007

journal

  • Journal of Clinical Investigation  Journal

abstract

  • In this issue of the JCI, two separate studies on MHC-bound peptides reopen the debate on the utility of peptides for the purposes of vaccination and treatment of autoimmune diseases. In the first study, by Wahlström et al., peptides bound to HLA-DR17 from bronchoalveolar lavage cells of sarcoidosis patients were analyzed in order to identify target antigens of the autoimmune response (see the related article beginning on page 3576). In the second study, by Le Gall et al., the modulation of epitope immunodominance and the processing and presentation of HIV peptides for MHC class I recognition were shown to be dependent on flanking residues that were N terminal to the natural epitopes (see the related article beginning on page 3563). Both studies highlight the tremendous therapeutic potential of MHC-bound peptides. They also emphasize that technical issues are still plaguing this field and hindering our understanding of MHC presentation in vivo.

subject areas

  • Antigen Presentation
  • Autoimmune Diseases
  • HIV-1
  • HLA-DR Antigens
  • Histocompatibility Antigens
  • Humans
  • Major Histocompatibility Complex
  • Peptides
  • Sarcoidosis
scroll to property group menus

Identity

PubMed Central ID

  • PMC2045625

International Standard Serial Number (ISSN)

  • 0021-9738

Digital Object Identifier (DOI)

  • 10.1172/jci33997

PubMed ID

  • 17975658
scroll to property group menus

Additional Document Info

start page

  • 3164

end page

  • 3166

volume

  • 117

issue

  • 11

©2021 The Scripps Research Institute | Terms of Use | Powered by VIVO

  • About
  • Contact Us
  • Support